(NASDAQ: HITI) High Tide's forecast annual revenue growth rate of 29.33% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 29.33%, and while it is forecast to beat the US market's average forecast revenue growth rate of 24.86%.
High Tide's revenue in 2025 is $411,775,362.On average, 6 Wall Street analysts forecast HITI's revenue for 2025 to be $48,332,132,690, with the lowest HITI revenue forecast at $46,696,021,564, and the highest HITI revenue forecast at $50,717,824,199. On average, 6 Wall Street analysts forecast HITI's revenue for 2026 to be $62,533,642,095, with the lowest HITI revenue forecast at $55,463,275,786, and the highest HITI revenue forecast at $70,753,905,227.
In 2027, HITI is forecast to generate $69,446,799,112 in revenue, with the lowest revenue forecast at $67,383,629,757 and the highest revenue forecast at $72,197,151,347.